We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You canĀ read more about our cookies before you choose.
Clinical commissioning policy: Alglucosidase alfa for patients with infantile-onset Pompe disease (all ages)
Alglucosidase alfa is recommended as a not for routine commissioning treatment option for infantile-onset Pompe disease (IOPD) within the criteria set out in this document.